Edgewise Therapeutics, Inc. (EWTX)
39.59
-0.43
(-1.07%)
USD |
NASDAQ |
Oct 07, 16:00
39.59
0.00 (0.00%)
After-Hours: 20:00
Edgewise Therapeutics Market Cap : 4.267B for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 4.313B |
| October 05, 2026 | 4.343B |
| October 02, 2026 | 4.462B |
| October 01, 2026 | 4.363B |
| September 30, 2026 | 4.376B |
| September 29, 2026 | 4.224B |
| September 28, 2026 | 4.288B |
| September 25, 2026 | 4.240B |
| September 24, 2026 | 4.436B |
| September 23, 2026 | 4.424B |
| September 22, 2026 | 4.797B |
| September 21, 2026 | 4.811B |
| September 18, 2026 | 4.884B |
| September 17, 2026 | 5.059B |
| September 16, 2026 | 4.897B |
| September 15, 2026 | 4.702B |
| September 14, 2026 | 4.809B |
| September 11, 2026 | 4.785B |
| September 10, 2026 | 4.624B |
| September 09, 2026 | 4.676B |
| September 08, 2026 | 4.723B |
| September 04, 2026 | 4.642B |
| September 03, 2026 | 4.521B |
| September 02, 2026 | 4.524B |
| September 01, 2026 | 4.554B |
| Date | Value |
|---|---|
| August 31, 2026 | 4.502B |
| August 28, 2026 | 4.609B |
| August 27, 2026 | 4.763B |
| August 26, 2026 | 4.783B |
| August 25, 2026 | 4.765B |
| August 24, 2026 | 4.820B |
| August 21, 2026 | 4.762B |
| August 20, 2026 | 4.666B |
| August 19, 2026 | 5.005B |
| August 18, 2026 | 4.754B |
| August 17, 2026 | 4.746B |
| August 14, 2026 | 4.760B |
| August 13, 2026 | 4.654B |
| August 12, 2026 | 4.695B |
| August 11, 2026 | 4.776B |
| August 10, 2026 | 4.805B |
| August 07, 2026 | 4.690B |
| August 06, 2026 | 4.787B |
| August 05, 2026 | 4.849B |
| August 04, 2026 | 4.818B |
| August 03, 2026 | 4.125B |
| July 31, 2026 | 4.131B |
| July 30, 2026 | 4.420B |
| July 29, 2026 | 4.272B |
| July 28, 2026 | 4.337B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 14.75M |
| CNBX Pharmaceuticals, Inc. | 0.2952M |
| Arvinas, Inc. | 487.14M |
| Fulcrum Therapeutics, Inc. | 281.11M |
| Definium Therapeutics, Inc. | 4.716B |
Market Cap Related Metrics
| PEG Ratio | -1.134 |
| Price to Book Value | 9.523 |
| Price | 39.59 |
| Earnings Yield | -4.67% |
| PEGY Ratio | -1.134 |